JAN 06, 2021 6:00 AM PST

COVID Patients Can't Stop and Smell the Roses

WRITTEN BY: Tara Fernandez

A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their sense of smell. On average, this olfactory dysfunction lingered for around three weeks. In a quarter of patients, their sense of smell was impaired for over two months.

The study, published in the Journal of Internal Medicine, was conducted by Jerome R. Lechien from Paris Saclay University and aimed to investigate how a marked decrease in olfactory function related to the severity of COVID-19 symptoms. Interestingly, only around five percent of moderate COVID cases and seven percent of critical cases lost their sense of smell.

"Olfactory dysfunction is more prevalent in mild COVID-19 forms than in moderate-to-critical forms, and 95% of patients recover their sense of smell at 6-months post-infection," said Lechien.

The temporary loss of smell, also known as anosmia, has been touted by experts as a better diagnostic indicator of the onset of infection than other common symptoms such as fever and cough. 

 

 

But why does SARS-CoV-2 infection interrupt patients’ ability to smell? Scientists initially suspected that the virus might be impacting the olfactory sensory neurons that detect and relay chemical signals from the nose to the brain. Follow up studies proved this not to be the case, as these neurons do not express the ACE2 receptor protein, the gateway for the coronavirus to enter human cells. 

Instead, SARS-CoV-2 is likely affecting the olfactory neurons’ support network—stem cells and cells lining blood vessels in the nasal passage. 

“Our findings indicate that the novel coronavirus changes the sense of smell in patients not by directly infecting neurons but by affecting the function of supporting cells,” explained Harvard Medical School scientist Sandeep Robert Datta.

On a positive note, COVID-related anosmia is a temporary condition.

“I think it’s good news, because once the infection clears, olfactory neurons don’t appear to need to be replaced or rebuilt from scratch,” added Datta. “But we need more data and a better understanding of the underlying mechanisms to confirm this conclusion.”

Sources: Harvard Medical School, Journal of Internal Medicine, EurekAlert.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 20, 2021
Clinical & Molecular DX
Wearable Health Monitors Powered by Sweaty Fingertips
JUL 20, 2021
Wearable Health Monitors Powered by Sweaty Fingertips
Fingertips have thousands of sweat-producing glands, churning out anywhere from 100 to 1,000 times more sweat than other ...
AUG 15, 2021
Microbiology
Lyme Disease Linked to Significantly Increased Suicide Risk
AUG 15, 2021
Lyme Disease Linked to Significantly Increased Suicide Risk
While about 30,000 cases of Lyme disease are reported to the CDC every year, the disease has been estimated to cause abu ...
OCT 27, 2021
Drug Discovery & Development
A novel drug delivery device to treat macular degeneration.
OCT 27, 2021
A novel drug delivery device to treat macular degeneration.
Last Friday, October 22nd, the United States Food and Drug Administration (FDA) approved a first of its kind d ...
NOV 04, 2021
Clinical & Molecular DX
Tech Offers a Brighter Tomorrow for Difficult-To-Treat Epilepsy Patients
NOV 04, 2021
Tech Offers a Brighter Tomorrow for Difficult-To-Treat Epilepsy Patients
It's difficult for neurologists to predict which patients living with epilepsy will respond to anti-seizure medicine ...
NOV 15, 2021
Cancer
Dogs Get Cancer Too
NOV 15, 2021
Dogs Get Cancer Too
“Cancer” isn’t a word anyone wants to hear from their doctor. However, many dog owners may not conside ...
DEC 01, 2021
Cardiology
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
DEC 01, 2021
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
Congestive Heart Failure (CHF) is a serious medical condition that results in the heart not being able to pump to meet t ...
Loading Comments...